Captor Therapeutics Spolka Akcyjna (CTX.WA)
PLN 47.8
(5.99%)
PLN 47.8
(5.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -49.25 Million | -22.94 Million | -28.47 Million | -595 Thousand | 4.39 Million | -2.13 Million |
| Net Income | -70.58 Million | -35.89 Million | -32.57 Million | -12.69 Million | -8.3 Million | -4.42 Million |
| Depreciation & Amortization | 5.44 Million | 7.09 Million | 7.35 Million | 6.6 Million | 4.45 Million | 2.58 Million |
| Deferred income taxes | -18.81 Million | - | 36 Thousand | 12 Thousand | - | - |
| Stock-based compensation | 4.58 Million | 8 Million | 9.49 Million | 1.73 Million | 550 Thousand | - |
| Change in working capital | 11.07 Million | 531 Thousand | -13.19 Million | 3.35 Million | 7.24 Million | -591 Thousand |
| Other non-cash items | 19.04 Million | -2.68 Million | 409 Thousand | 392 Thousand | 452 Thousand | 296 Thousand |
| Investing Cash Flow | 16.66 Million | -17.63 Million | -5.11 Million | -212 Thousand | -229 Thousand | -100 Thousand |
| Investments in PPE | -3 Million | -892 Thousand | -5.11 Million | -212 Thousand | -229 Thousand | -100 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -50.45 Million | -53.53 Million | - | - | - | - |
| Sales/Maturities of investments | 70.11 Million | 33.87 Million | - | - | - | - |
| Other Investing Activities | 22.93 Million | 2.92 Million | - | - | - | - |
| Financing Cash Flow | 37.25 Million | -6.32 Million | 140.87 Million | -881 Thousand | 5.72 Million | 3.09 Million |
| Debt repayment | -1.64 Million | -5.75 Million | -209 Thousand | -6.1 Million | - | -47 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 38.9 Million | 4000.00 | 148.24 Million | 5.6 Million | 10.2 Million | 6.1 Million |
| Other Financing Activities | 38.58 Million | -575 Thousand | -7.15 Million | -378 Thousand | -4.47 Million | -2.96 Million |
| Accounts receivables | -3.07 Million | 1.52 Million | -9.87 Million | 5000.00 | 542 Thousand | -1.9 Million |
| Accounts payables | -274 Thousand | 3.36 Million | -8.78 Million | 312 Thousand | 172 Thousand | 2.21 Million |
| Inventory | - | - | - | 2000.00 | - | - |
| Other working capital | 14.42 Million | -4.36 Million | 5.46 Million | 3.04 Million | 6.52 Million | -894 Thousand |
| Cash at beginning of period | 71.03 Million | 117.94 Million | 10.65 Million | 12.34 Million | 2.44 Million | 1.58 Million |
| Cash at end of period | 75.7 Million | 71.03 Million | 117.94 Million | 10.65 Million | 12.34 Million | 2.44 Million |
| Capital Expenditure | -3 Million | -892 Thousand | -5.11 Million | -212 Thousand | -229 Thousand | -100 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.66 Million | -46.9 Million | 107.28 Million | -1.68 Million | 9.89 Million | 861 Thousand |
| Free Cash Flow | -52.25 Million | -23.84 Million | -33.58 Million | -807 Thousand | 4.16 Million | -2.23 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.98 Million | -9.44 Million | -70.58 Million | -11.48 Million | -15.77 Million | -29.09 Million |
| Depreciation & Amortization | 1.34 Million | 1.11 Million | 5.44 Million | 1.13 Million | 1.21 Million | 1.47 Million |
| Deferred income taxes | - | - | -18.81 Million | -9.8 Million | -16 Thousand | -5000.00 |
| Stock-based compensation | - | -52 Thousand | 4.58 Million | 989 Thousand | 1.07 Million | 1.2 Million |
| Change in working capital | 677 Thousand | -1.41 Million | 11.07 Million | -7.58 Million | 10.48 Million | 3.83 Million |
| Other non-cash items | 1.62 Million | -330 Thousand | 19.04 Million | 9.92 Million | -350 Thousand | -1.64 Million |
| Investing Cash Flow | -4.16 Million | 416 Thousand | 16.66 Million | 15.92 Million | 684 Thousand | -1.56 Million |
| Investments in PPE | 7.02 Million | - | -3 Million | -236 Thousand | -1.76 Million | -933 Thousand |
| Acquisitions | - | - | - | - | 1.76 Million | 933 Thousand |
| Investment purchases | - | - | -50.45 Million | -1000.00 | -16.15 Million | -18.11 Million |
| Sales/Maturities of investments | - | - | 70.11 Million | 16.16 Million | 18.11 Million | 16.17 Million |
| Other Investing Activities | 247 Thousand | 416 Thousand | 22.93 Million | 16.74 Million | -1.27 Million | 375 Thousand |
| Financing Cash Flow | -1.34 Million | -969 Thousand | 37.25 Million | 38.16 Million | 705 Thousand | -48 Thousand |
| Debt repayment | -1.34 Million | -883 Thousand | -1.64 Million | -732 Thousand | -766 Thousand | -4000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2000.00 | - | 38.9 Million | 38.89 Million | 4000.00 | - |
| Other Financing Activities | -1.34 Million | -86 Thousand | 38.58 Million | 38.76 Million | 701 Thousand | -44 Thousand |
| Accounts receivables | 349 Thousand | 1.84 Million | -3.07 Million | -4.19 Million | 865 Thousand | -752 Thousand |
| Accounts payables | 1.65 Million | -1.78 Million | -274 Thousand | -2.35 Million | 1 Million | -2.05 Million |
| Inventory | - | - | - | - | 26 Thousand | - |
| Other working capital | -1.32 Million | -1.48 Million | 14.42 Million | -1.04 Million | 8.58 Million | 6.64 Million |
| Cash at beginning of period | 64.88 Million | 75.69 Million | 71.03 Million | 38.45 Million | 40.43 Million | 66.27 Million |
| Cash at end of period | 56.52 Million | 64.88 Million | 75.7 Million | 75.7 Million | 38.45 Million | 40.43 Million |
| Capital Expenditure | 7.02 Million | - | -3 Million | -236 Thousand | -1.76 Million | -933 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
| Net cash flow / Change in cash | -8.36 Million | -10.8 Million | 4.66 Million | 37.25 Million | -1.98 Million | -25.83 Million |
| Free Cash Flow | - | -10.25 Million | -52.25 Million | -17.06 Million | -5.13 Million | -25.15 Million |
LKPSEC
002712
SWASTIKA
HOWARHO
MARIS
PRPM